Why Making Dramatic Moves: Banco Bradesco S.A. (NYSE:BBD), PulteGroup, Inc. (NYSE:PHM), Donaldson Company, Inc. (NYSE:DCI), IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), Epizyme (NASDAQ:EPZM)

Banco Bradesco SA (NYSE:BBD) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.02. On average, analysts predict that Banco Bradesco SA will post $1.52 earnings per share for the current fiscal year. Banco Bradesco S.A. (NYSE:BBD) in last trading activity increased 5.18% to close at $15.43. Company weekly performance is 2.66% while its quarterly performance stands at -2.40%. Banco Bradesco S.A. (NYSE:BBD) is -17.31% away from its 52 week high.Compass Point reiterated their neutral rating on shares of PulteGroup (NYSE:PHM) in a research note released on Monday morning. On last trading day PulteGroup, Inc. (NYSE:PHM) increased 4.83% to close at $18.23. Its volatility for the week is 4.54% while volatility for the month is 2.92%. PHM's sales growth for past 5 years was -1.90% and its EPS growth for past 5 years was 25.80%. PulteGroup, Inc. (NYSE:PHM) monthly performance is -4.45%.Donaldson Company Inc. (NYSE:DCI) announces the launch of the Torit PowerCore VL dust collector that was designed to meet the specific requirements of applications that generate light and fibrous dust. On last trading day Donaldson Company, Inc. (NYSE:DCI) increased 1.16% to close at $38.31. Its volatility for the week is 2.48% while volatility for the month is 1.82%. DCI's sales growth for past 5 years was 5.80% and its EPS growth for past 5 years was 16.20%. Donaldson Company, Inc. (NYSE:DCI) monthly performance is -7.89%.Intellipharmaceutics International Inc. (NASDAQ:IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months ended August 31, 2014. All dollar amounts referenced herein are in United States dollars unless otherwise noted. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has 39.16% insider ownership while its institutional ownership stands at 0.50%. In last trading activity company's stock closed at $2.74.Epizyme Inc. (NASDAQ:EPZM) announces the presentation of its clinical and pre-clinical data on inhibitors of Histone Methyltransferase at the American Society of Hematology’s 56th annual meeting. The meeting will take place between December 6 and 9 in San Francisco, Calif. According to Robert Gould, President and CEO at Epizyme, the company continues its clinical and scientific leadership in HMT field. The next two months will be crucial for the company as the company will share its two lead program’s clinical data with EPZ-6438 data’s oral presentation at the EORTC-NCI-AACR symposium. On Friday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $27.11.